Reply to the comment from Bjerre et al

Pharmacogenet Genomics. 2015 Mar;25(3):148. doi: 10.1097/FPC.0000000000000115.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carboxylic Ester Hydrolases / genetics*
  • Coronary Disease / therapy*
  • Cytochrome P-450 CYP2C19 / genetics*
  • Female
  • Humans
  • Male
  • Platelet Aggregation Inhibitors / adverse effects*
  • Ticlopidine / analogs & derivatives*

Substances

  • Platelet Aggregation Inhibitors
  • Cytochrome P-450 CYP2C19
  • Carboxylic Ester Hydrolases
  • Ticlopidine